StockUK listing UK0QLNLSEValue Trap

Tecan Group AG(0QLN) Stock Analysis

GBP --+0.00%
Reward42Moderate
Risk37Moderate
75%Data
Thin -13% profit margin
GBP —+0.00 (+0.00%) Previous close · LSE
Market cap 1.39Bn
Reward Rating42 Moderate reward assessment · 75% data coverage
Bottom 10% of stocksView factors
Risk Rating37 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on 0QLN to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Tecan Group AG?

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

AI Brief Pro

The brief on Tecan Group AG

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Tecan Group AG?

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company is listed on the LSE in UK, with a market capitalisation of 1.39B, and a P/E ratio of 0.2x.

Financial Highlights

Investment Breakdown

Growth
Revenue growth is subdued, limiting near-term earnings expansion.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (42)
Company Information
SectorN/A
IndustryN/A
P/E Ratio0.2215
Beta1.085
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.